Goldman Sachs’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Sell |
108,179
-64,254
| -37% | -$329K | ﹤0.01% | 4200 |
|
|
2025
Q1 | $236K | Sell |
172,433
-314,455
| -65% | -$431K | ﹤0.01% | 4611 |
|
|
2024
Q4 | $1.5M | Sell |
486,888
-56,609
| -10% | -$175K | ﹤0.01% | 3671 |
|
|
2024
Q3 | $4.18M | Sell |
543,497
-71,421
| -12% | -$550K | ﹤0.01% | 2877 |
|
|
2024
Q2 | $5.28M | Buy |
614,918
+1,216
| +0.2% | +$10.4K | ﹤0.01% | 2567 |
|
|
2024
Q1 | $4.87M | Buy |
613,702
+164,487
| +37% | +$1.31M | ﹤0.01% | 2587 |
|
|
2023
Q4 | $4.45M | Buy |
449,215
+334,355
| +291% | +$3.31M | ﹤0.01% | 2680 |
|
|
2023
Q3 | $1.29M | Buy |
114,860
+24,293
| +27% | +$274K | ﹤0.01% | 3368 |
|
|
2023
Q2 | $301K | Buy |
90,567
+9,408
| +12% | +$31.2K | ﹤0.01% | 4222 |
|
|
2023
Q1 | $321K | Buy |
81,159
+11,125
| +16% | +$43.9K | ﹤0.01% | 4302 |
|
|
2022
Q4 | $508K | Sell |
70,034
-204,552
| -74% | -$1.48M | ﹤0.01% | 4081 |
|
|
2022
Q3 | $994K | Buy |
274,586
+194,191
| +242% | +$703K | ﹤0.01% | 3821 |
|
|
2022
Q2 | $364K | Sell |
80,395
-21,391
| -21% | -$96.9K | ﹤0.01% | 4581 |
|
|
2022
Q1 | $772K | Buy |
101,786
+19,180
| +23% | +$145K | ﹤0.01% | 4297 |
|
|
2021
Q4 | $904K | Buy |
+82,606
| New | +$904K | ﹤0.01% | 4110 |
|